Mergers And Acquisitions

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.

We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.

The Vice President, M&A at Iterative Health will lead the evaluation, structuring, negotiation, and execution of strategic acquisitions and other inorganic growth opportunities. Partnering closely with the Chief Development Officer, executive leadership, and cross-functional teams, this leader will own the end-to-end transaction lifecycle, from market mapping and partial target sourcing through due diligence, closing, and post-acquisition integration. This individual will also help establish a disciplined, scalable M&A function that supports the company's long-term strategic and financial objectives, including opportunities to expand our clinical research site network through acquisitions and de novo development. 

Where You’ll Drive Impact 

M&A Strategy & Sourcing

• Partner with the Chief Development Officer, executive leadership and both internal and external stakeholders to lead the identification, evaluation, structuring, negotiation, and execution of acquisitions and other strategic transactions that advance Iterative Health's growth strategy.
• Develop and execute an M&A strategy aligned with company growth priorities and financial objectives.
• Identify, evaluate, and prioritize acquisition and de novo opportunities across clinical research, healthcare services, life sciences, and adjacent markets.
• Build a robust pipeline of acquisition targets through industry relationships, proprietary sourcing, investors, and external advisors.
• Conduct market mapping and competitive analysis to assess strategic fit, growth potential, and value creation opportunities.

Transaction Execution & Due Diligence

• Lead the end-to-end M&A lifecycle, including valuation, financial modeling, due diligence, deal structuring, negotiation, and closing.
• Coordinate cross-functional diligence across finance, legal, operations, people, technology, and regulatory functions to identify risks and opportunities.
• Develop acquisition models, return analyses, pro forma projections, and assessments of synergies, capital requirements, and transaction economics.